BACKGROUND AND AIMS: CD71+ erythroid cells are enriched during pregnancy with immuno suppressive properties. We investigated the frequency and functionality of CD71+ erythroid cells in peripheral blood, cord blood, and placenta of inflammatory bowel disease [IBD] patients versus healthy controls [HCs]. We aimed to determine their role in IBD pathogenesis during pregnancy. METHODS: Peripheral blood was collected at preconception, the first, second and third trimesters, and postpartum. Cord blood and placental tissues were collected at the time of birth. Cells from different specimens were subjected to immune-phenotyping and functional assays. CD71+ erythroid cells were purified for quantitative polymerase chain reaction [qPCR] analysis. Using an allogeneic mouse model of pregnancy, the effects of CD71+ erythroid cells depletion on intestinal homeostasis and dysbiosis was studied. RESULTS: IBD patients had lower CD71+ erythroid cells during pregnancy compared with HCs. Placenta and cord blood CD71+ erythroid cells from IBD patients exhibited impaired functionality and expressed lower inhibitory molecules including VISTA, TGF-β, and reactive oxygen species [ROS]. Lower CD71+ erythroid cells were correlated with reduced regulatory T cells and increased immune-activation in IBD patients. Depletion of CD71+ erythroid cells in an allogeneic pregnancy model resulted in upregulation of TLRs, IL-6, and CXCL-1, and enhanced production of TNF-α, in intestinal tissues. In contrast, TGF-β gene expression was reduced. Excessive inflammatory response in the gut [e.g. TNF-α] affects intestinal integrity and CD71+ erythroid cells impact on the gut's bacterial composition. CONCLUSIONS: Reduced frequency and/or impaired functionality of CD71+ erythroid cells during pregnancy may predispose IBD patients to a more pro-inflammatory milieu in their gastrointestinal tract, characterised by lower Tregs, higher IL-6, and TNF-α, and dysbiosis.
BACKGROUND AND AIMS: CD71+ erythroid cells are enriched during pregnancy with immuno suppressive properties. We investigated the frequency and functionality of CD71+ erythroid cells in peripheral blood, cord blood, and placenta of inflammatory bowel disease [IBD] patients versus healthy controls [HCs]. We aimed to determine their role in IBD pathogenesis during pregnancy. METHODS: Peripheral blood was collected at preconception, the first, second and third trimesters, and postpartum. Cord blood and placental tissues were collected at the time of birth. Cells from different specimens were subjected to immune-phenotyping and functional assays. CD71+ erythroid cells were purified for quantitative polymerase chain reaction [qPCR] analysis. Using an allogeneic mouse model of pregnancy, the effects of CD71+ erythroid cells depletion on intestinal homeostasis and dysbiosis was studied. RESULTS: IBD patients had lower CD71+ erythroid cells during pregnancy compared with HCs. Placenta and cord blood CD71+ erythroid cells from IBD patients exhibited impaired functionality and expressed lower inhibitory molecules including VISTA, TGF-β, and reactive oxygen species [ROS]. Lower CD71+ erythroid cells were correlated with reduced regulatory T cells and increased immune-activation in IBD patients. Depletion of CD71+ erythroid cells in an allogeneic pregnancy model resulted in upregulation of TLRs, IL-6, and CXCL-1, and enhanced production of TNF-α, in intestinal tissues. In contrast, TGF-β gene expression was reduced. Excessive inflammatory response in the gut [e.g. TNF-α] affects intestinal integrity and CD71+ erythroid cells impact on the gut's bacterial composition. CONCLUSIONS: Reduced frequency and/or impaired functionality of CD71+ erythroid cells during pregnancy may predispose IBD patients to a more pro-inflammatory milieu in their gastrointestinal tract, characterised by lower Tregs, higher IL-6, and TNF-α, and dysbiosis.
Authors: C Gasche; T Waldhoer; T Feichtenschlager; C Male; A Mayer; C Mittermaier; W Petritsch Journal: Am J Gastroenterol Date: 2001-08 Impact factor: 10.864
Authors: Lene Riis; Ida Vind; Patrizia Politi; Frank Wolters; Severine Vermeire; Epameinondas Tsianos; João Freitas; Ioannis Mouzas; Victor Ruiz Ochoa; Colm O'Morain; Selwyn Odes; Vibeke Binder; Bjørn Moum; Reinhold Stockbrügger; Ebbe Langholz; Pia Munkholm Journal: Am J Gastroenterol Date: 2006-07 Impact factor: 10.864
Authors: Li Yang; Pranavkumar Shivakumar; Jeremy Kinder; Sing Sing Way; Bryan Donnelly; Reena Mourya; Zhenhua Luo; Jorge A Bezerra Journal: JCI Insight Date: 2020-06-04
Authors: Nadine Beckmann; Franziska Huber; Marc Hanschen; Barbara St Pierre Schneider; Vanessa Nomellini; Charles C Caldwell Journal: Front Immunol Date: 2020-05-08 Impact factor: 7.561
Authors: Nardhy Gomez-Lopez; Roberto Romero; Sonia S Hassan; Gaurav Bhatti; Stanley M Berry; Juan Pedro Kusanovic; Percy Pacora; Adi L Tarca Journal: Front Immunol Date: 2019-12-17 Impact factor: 7.561
Authors: Shokrollah Elahi; Marco Antonio Vega-López; Vladimir Herman-Miguel; Carmen Ramírez-Estudillo; Javier Mancilla-Ramírez; Bruce Motyka; Lori West; Olaide Oyegbami Journal: Front Immunol Date: 2020-11-24 Impact factor: 7.561